z-logo
Premium
Tinea imbricata or Tokelau
Author(s) -
Bonifaz Alexandro,
ArcherDubon Carla,
Saúl Amado
Publication year - 2004
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/j.1365-4632.2004.02171.x
Subject(s) - medicine , dermatology , terbinafine , dermatophyte , keratolytic , griseofulvin , disease , pathology , antifungal , itraconazole
Tinea imbricata (TI) or Tokelau is a superficial mycosis caused by Trichophyton concentricum , an anthropophilic dermatophyte. It is endemic in some islands of the South Pacific (Polynesia), South‐East Asia, Central and South America, and Mexico, and is most often seen in individuals living in primitive and isolated conditions. The skin lesions are characteristically concentric and lamellar ( imbricata : in Latin, tiled) plaques of scale. Predisposing conditions include humidity, inheritance, and immunologic factors. The diagnosis is usually made on clinical grounds, supported by skin scrapings and culture. Tokelau is a chronic and highly relapsing disease and, although no first‐line treatment exists, best results are obtained with oral griseofulvin and terbinafine and a topical combination of keratolytic ointments, such as Whitfield's. TI is a disease model that allows the correlation of a series of environmental, genetic, immunologic, and therapeutic conditions.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here